BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for SAB Biotherapeutics, Inc. (SABS)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for SAB Biotherapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-12-04
4:33 pm
Purchase		 2023-11-22 13G SAB Biotherapeutics, Inc.
SABS		 BIOTECHNOLOGY VALUE FUND L P 917,828
9.990%		 917,828increase
(New Position)		 Filing